0.00Open0.00Pre Close0 Volume0 Open Interest92.00Strike Price0.00Turnover4486.74%IV-19.19%PremiumDec 13, 2024Expiry Date14.81Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9804Delta0.0074Gamma5.59Leverage Ratio-110.9650Theta0.0000Rho-5.48Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet